Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKromek Share News (KMK)

Share Price Information for Kromek (KMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.85
Bid: 7.50
Ask: 8.20
Change: 0.00 (0.00%)
Spread: 0.70 (9.333%)
Open: 7.85
High: 7.85
Low: 7.85
Prev. Close: 7.85
KMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Amphion Innovations Confident After Motif IPO, 2014 Asset Value Fall

Tue, 23rd Jun 2015 09:28

LONDON (Alliance News) - Amphion Innovations PLC Tuesday posted a decline in net asset value for 2014, hit by a fall in the share price of Kromek Group PLC, but expressed confidence for the coming year on the back of the initial public offering of portfolio company Motif Bio PLC.

Amphion invests and partners with companies in the medical and technologies sectors.

The company had a net asset value per share of USD0.011 at the end of 2014, compared to USD0.10 at the end of 2013. This was primarily due to the fall in the share price of radiation technology firm Kromek, which reduced the value of Amphion's holding in Kromek.

The company said that despite repeated profit warnings since Kromek's initial public offering and its disappointing share price, it continues to believe that Kromek's technology "holds great promise".

Amphion posted a pretax loss of USD10.9 million for 2014, widened from a pretax loss of USD4.9 million, mostly as a result of a USD10.0 million fair value loss on investments. Revenue fell to USD484,700 from USD1.0 million.

Motif Bio listed on AIM in early April, and since then has seen a rise in its share price, which Amphion believes on a pro-forma basis will result in a "massive improvement" in its balance sheet and net asset value.

"As expected, the recovery in the stock market and the IPO market in particular has led to an improvement in the overall climate for our business," the company said in a statement.

"With the transformation in Motif's business, we have been able to take advantage of these improved market conditions and with the sharp rise in the valuation of Motif since the IPO we have been able to approach the equity capital markets again for the first time in over seven years," Amphion added.

Motif Bio said Tuesday it raised GBP22 million in a share placing, following which Amphion's diluted holding in the fellow AIM-list firm will be 29%.

Shares in Amphion are trading down 3.1% at 6.66 pence Tuesday morning.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
1 Jun 2021 15:51

EXECUTIVE CHANGES: Tekmar hires former Kromek CFO; Redx chair departs

EXECUTIVE CHANGES: Tekmar hires former Kromek CFO; Redx chair departs

Read more
11 May 2021 15:07

Kromek reports solid momentum through second half

(Sharecast News) - Medical, security screening and nuclear detection technology company Kromek updated the market on its trading in the year just ended on Tuesday, confirming that after orders and shipments across its segments resumed in the final two months of the first half, it entered the second half with an "extensive" commercial pipeline and increased commercial activity.

Read more
11 May 2021 14:12

TRADING UPDATES: Treatt hikes dividend as earnings jump in year

TRADING UPDATES: Treatt hikes dividend as earnings jump in year

Read more
9 Mar 2021 13:34

IN BRIEF: Kromek wins nuclear detection contract worth USD960,000

IN BRIEF: Kromek wins nuclear detection contract worth USD960,000

Read more
1 Mar 2021 15:34

TRADING UPDATES: 1Spatial expects full-year results ahead of forecasts

TRADING UPDATES: 1Spatial expects full-year results ahead of forecasts

Read more
12 Feb 2021 15:46

Kromek raising up to £13m with new and existing investors

(Sharecast News) - Medical, security screening and nuclear-focussed detection technology company Kromek announced a fundraising of up to £13m before expenses on Friday, in a bid to de-risk and commercialise its biosecurity and pathogen detectors, among other things.

Read more
12 Feb 2021 12:07

IN BRIEF: Kromek Plans Fundraise, Intuitive Investments To Buy Shares

IN BRIEF: Kromek Plans Fundraise, Intuitive Investments To Buy Shares

Read more
13 Jan 2021 11:21

Kromek Interim Loss Widens; Develops Airborne Virus Detection System

Kromek Interim Loss Widens; Develops Airborne Virus Detection System

Read more
6 Jan 2021 16:13

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
16 Dec 2020 15:28

UK EXECUTIVE CHANGE SUMMARY: Mitie Adds Interserve Chair To Board

UK EXECUTIVE CHANGE SUMMARY: Mitie Adds Interserve Chair To Board

Read more
8 Dec 2020 17:16

IN BRIEF: Kromek Wins Contract Extension For Network Services

IN BRIEF: Kromek Wins Contract Extension For Network Services

Read more
3 Dec 2020 20:51

IN BRIEF: Kromek Launches World's Smallest Radioisotope Device

IN BRIEF: Kromek Launches World's Smallest Radioisotope Device

Read more
2 Nov 2020 20:03

UK TRADING UPDATE SUMMARY: Sensyne App Used In Oxford Covid Study

UK TRADING UPDATE SUMMARY: Sensyne App Used In Oxford Covid Study

Read more
29 Oct 2020 16:33

UK EXECUTIVE CHANGE SUMMARY: Biome Tech Hires Former Filtronic CEO

UK EXECUTIVE CHANGE SUMMARY: Biome Tech Hires Former Filtronic CEO

Read more
14 Oct 2020 20:19

IN BRIEF: Kromek Developing New System For Use In Cancer Surgery

IN BRIEF: Kromek Developing New System For Use In Cancer Surgery

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.